Nuveen Asset Management, LLC Dyne Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 266,404 shares of DYN stock, worth $5.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

266,404

Previous 276,414 3.62%

Holding current value

$5.02 Million

Previous $9.93 Million 36.78%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$23.56 - $35.55 $235,835 - $355,855	-10,010 Reduced 3.62%	266,404 $6.28 Million
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $11.4 Million - $16.8 Million	-357,222 Reduced 56.38%	276,414 $9.93 Million
Q2 2024 Aug 09, 2024	BUY	$23.65 - $35.63 $2.34 Million - $3.52 Million	98,875 Added 18.49%	633,636 $22.4 Million
Q1 2024 May 13, 2024	BUY	$13.06 - $29.18 $5.02 Million - $11.2 Million	384,432 Added 255.73%	534,761 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$6.62 - $13.64 $16,238 - $33,458	2,453 Added 1.66%	150,329 $2 Million

Q3 2023 Nov 14, 2023	SELL	$8.6 - $12.18 $9,434 - $13,361	-1,097 Reduced 0.74%	147,876 $1.32 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $122,490 - $205,060	14,360 Added 10.67%	148,973 $1.68 Million
Q1 2023 May 15, 2023	SELL	$10.88 - $15.0 $121,507 - $167,520	-11,168 Reduced 7.66%	134,613 $1.55 Million
Q4 2022 Feb 14, 2023	SELL	$9.37 - $13.8 $148,842 - $219,213	-15,885 Reduced 9.83%	145,781 $1.69 Million
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $280,958 - $591,963	-39,022 Reduced 19.44%	161,666 $2.05 Million
Q2 2022 Aug 15, 2022	BUY	$4.36 - $10.5 $252,282 - $607,561	57,863 Added 40.51%	200,688 $1.38 Million
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $18,790 - $35,362	2,882 Added 2.06%	142,825 $1.28 Million
Q4 2021 Feb 14, 2022	SELL	$11.89 - $16.07 $69,378 - $93,768	-5,835 Reduced 4.0%	139,943 $1.66 Million
Q3 2021 Nov 12, 2021	SELL	$15.6 - $21.46 $92,866 - $127,751	-5,953 Reduced 3.92%	145,778 $2.37 Million
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $1.76 Million - $2.46 Million	110,223 Added 265.55%	151,731 $3.19 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $254,660 - $532,967	18,190 Added 78.01%	41,508 $644,000
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $391,975 - $558,232	23,318 New	23,318 $490,000

Others Institutions Holding DYN

# of Institutions

227

Shares Held

148M

Call Options Held

184K

Put Options Held

243K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $975M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Dyne Therapeutics, Inc. Transaction History